Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer

NCT00403130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Gemcitabine
DRUG: Paclitaxel
DRUG: Bevacizumab

Sponsor

George Albert Fisher

Collaborators

[object Object]
[object Object]